Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 28:27:100763.
doi: 10.1016/j.ymgmr.2021.100763. eCollection 2021 Jun.

Hyperleucinosis during infections in maple syrup urine disease post liver transplantation

Laura Guilder  1 , Carlos E Prada  2 , Sofia Saenz  2 , Shailly Jain-Ghai  3 , Natalya Karp  4 , George Mazariegos  5 , Suzanne Ratko  4 , Ramona Salvarinova  6 , Saadet Mercimek-Andrews  1   3
Affiliations

Hyperleucinosis during infections in maple syrup urine disease post liver transplantation

Laura Guilder et al. Mol Genet Metab Rep. .

Abstract

Maple syrup urine disease (MSUD) is due to biallelic variants in one of the three genes: BCKDHA, BCKDHB, and DBT. Branched-chain alpha-ketoacid dehydrogenase complex deficiency and elevated leucine, valine, isoleucine and alloisoleucine in body fluids are the results. We report hyperleucinosis during intercurrent illnesses in six patients with MSUD post liver transplantation. Patient charts were retrospectively reviewed. Data was entered into an Excel Database. Literature was reviewed. Six patients with MSUD were included who had post liver transplantation hyperleucinosis during an intercurrent illness. Five had encephalopathy. One received hemodialysis for the management of hyperleucinosis. All patients had unrestricted diet. Additionally, there were five patients (one patient included into the current study) reported in the literature. We suggested management considerations for the follow-up of patients with MSUD post liver transplantation after the first episode of unexplained encephalopathy or signs of acute hyperleucinosis during intercurrent illness due to our clinical experience: 1) Healthy: Unrestricted diet and monitoring of leucine levels; 2) Illness: a) home illness management: increased carbohydrate intake b) illness management at hospital: intravenous dextrose, intravenous lipid and daily plasma amino acid monitoring. We report hyperleucinosis and/or encephalopathy as a rare event post liver transplantation in MSUD as a multicenter case series. Hyperleucinosis and/or encephalopathy may occur in both related and unrelated donor liver transplantation. Based on the long-term follow-up of those patients, these suggested management considerations may be revised as per the patients' needs.

Keywords: Branched chain amino acids; Hyperleucinosis; Liver transplantation; Maple syrup urine disease.

PubMed Disclaimer

References

    1. Strauss K.A., Puffenberger E.G., Carson V.J. Maple syrup urine disease. In: Adam M.P., Ardinger H.H., Pagon R.A., Wallace S.E., LJH Bean, Stephens K., Amemiya A., editors. GeneReviews [Internet] University of Washington; Seattle (WA): 2006 Jan 30. [Updated 2020 Apr 23]. (1993–2020)
    1. Edelmann L., Wasserstein M.P., Kornreich R., Sansaricq C., Snyderman S.E., Diaz G.A. Maple syrup urine disease: identification and carrier-frequency determination of a novel founder mutation in the Ashkenazi Jewish population. Am. J. Hum. Genet. 2001;69:863–868. - PMC - PubMed
    1. Puffenberger E.G. Genetic heritage of the old order Mennonites of southeastern Pennsylvania. Am. J. Med. Genet. C: Semin. Med. Genet. 2003;121C:18–31. - PubMed
    1. Kalkan Ucar S., Coker M., Habif S. The first use of N-carbamylglutamate in a patient with decompensated maple syrup urine disease. Metab. Brain Dis. 2009;24(3):409–414. - PubMed
    1. Puckett R.L., Lorey F., Rinaldo P. Maple syrup urine disease: further evidence that newborn screening may fail to identify variant forms. Mol. Genet. Metab. 2010;100:136–142. - PubMed

LinkOut - more resources